NURO neurometrix.com: Company Value to Revenue

Official company branding of NeuroMetrix (NURO)

Limited pricing power due to low insurance coverage makes demand elastic, which impacts the business valuation based on EV/Sales. The value shows the current magnitude of this metric. NeuroMetrix, Inc. (NURO) is developing Quell to combat neuropathy amid a growing market for non-pharmacological pain relief. Direct mailing of devices to patients minimizes clinic costs and stabilizes logistics.

neurometrix.com (NURO): Enterprise Value-to-Revenue Ratio from 07/04/2022 to 11/20/2026

NURO (NeuroMetrix Corporation): analytical breakdowns and indicator data

- current quotes and average value forecast:
Initial company analysis:NeuroMetrix, Inc., NURO
Manufactured products of NeuroMetrix Corp

This indicator measures the enterprise value of the business minus net debt per unit of sales, reflecting the sensitivity of capitalization to operational efficiency. Stable electronics supplies for NeuroMetrix, Inc. (NURO) support profitability, allowing the EV/Revenue ratio on GURU.Markets to be used for identifying trend reversals and extreme valuation points prior to the publication of financial statements.

Competitor analysis for NeuroMetrix, Inc.

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Monogram Technologies Inc (MGRM) - Enterprise Value-to-Revenue Ratio|STSS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio InfuSystem Holdings, Inc.|Enterprise Value-to-Revenue Multiple Utah Medical Products UTMD|EV/Sales Multiple KRMD|Total Company Value-to-Revenue Ratio Nyxoah, S.A.|Microbot Medical Inc - Company Value to Revenue|Total Company Value-to-Revenue Ratio Pro-Dex Inc. (PDEX)|Zentek - EV/Sales Multiple|Elutia (ELUT) - Company Value to Revenue|Milestone Scientific Inc (MLSS) - Enterprise Value-to-Revenue Ratio|NXGL - Total Company Value-to-Revenue Ratio|Company Value to Revenue RVP|Harvard Bioscience, Inc. (HBIO) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple FEMY|EV/Sales Multiple Meihua Medical Technologies (MHUA)|EV/Sales Multiple POAI (Predictive Oncology)|CJMB - Company Value to Revenue|ATRI: Company Value to Revenue